Skip to main content
. 2023 Dec 15;15:925–951. doi: 10.2147/BCTT.S424624

Figure 1.

Figure 1

Different immunotherapeutic options for cancer management: main focus is to block immune checkpoints, use of genetically engineered cells, personalized and cytokines therapy, and use of monoclonal antibodies specific to antigens from cancer cells.